サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654684

食道鏡・胃カメラの世界市場：2025年～2033年

Global Esophagoscopes and Gastroscopes Market - 2025-2033

出版日
ページ情報
英文 153 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
食道鏡・胃カメラの世界市場：2025年～2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 153 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の食道鏡・胃カメラ市場は、2024年に18億米ドルに達し、2033年までには29億米ドルに達すると予測され、予測期間中の2025年から2033年のCAGRは5.6%で成長します。

食道鏡は、喉と胃をつなぐ管である食道を検査するために使用される特殊な内視鏡器具です。これらの器具は、酸逆流症（GERD）、食道がん、食道狭窄、異物除去などの食道疾患の診断に利用されます。食道鏡には硬性食道鏡と軟性食道鏡があり、軟性食道鏡の方が食道を快適に曲げたり移動させたりすることができるため、より一般的に使用されています。

胃カメラは、胃や小腸の上部を検査するための内視鏡器具です。胃炎、消化性潰瘍、胃がん、ピロリ菌感染などの診断や治療に重要な役割を果たします。食道鏡と同様、胃カメラにも硬質タイプと軟質タイプがあり、胃や十二指腸の様々な部位に容易にアクセスできる軟質タイプの方が広く採用されています。

食道鏡・胃カメラの需要は、胃腸（GI）疾患の有病率の増加、内視鏡技術の進歩、ヘルスケア投資の拡大など、いくつかの重要な要因によって牽引されています。胃炎、消化性潰瘍、胃食道逆流症（GERD）、食道がん、胃がんなどの消化器疾患の罹患率の増加は、診断および治療的内視鏡処置の需要を大きく促進しています。例えば、33カ国で実施された最近の世界の調査では、世界の40％以上の人々が胃腸障害に罹患しており、発展途上国での有病率が高いことが判明しています。

市場力学：

促進要因と抑制要因

使い捨て食道鏡・胃カメラの採用増加

使い捨て食道鏡・胃カメラの採用が増加していることは、食道鏡・胃カメラ市場の成長を大きく後押ししており、予測期間中も市場を牽引すると予想されます。COVID-19の大流行により、ヘルスケア環境、特に交差汚染のリスクが高い内視鏡処置における感染予防への注目が高まりました。再利用可能な食道鏡・胃カメラは、適切に滅菌されていない場合、院内感染（HAI）のトランスミッションなど深刻な健康リスクをもたらす可能性があります。使い捨て食道鏡・胃カメラへの選好が高まるにつれ、病院やヘルスケアプロバイダーが患者の安全を優先するようになり、市場導入が拡大しています。

例えば、2024年7月、EvoEndo, Inc.は、モデルLE 85シングルユース胃カメラをリリースし、鎮静剤を使用しない上部消化管の経鼻内視鏡検査（TNE）に新たな選択肢を提供しました。LE 85型単回使用胃カメラは、十二指腸へのアクセスが不要な場合に、患者の快適性と医師の操作性を最適化することを目的としています。患者の安全性を考慮し、シャフトの長さを短くし、柔軟性を高めています。

患者や医師が、より早い回復時間と合併症発生率の低減を提供する低侵襲性処置を支持し続ける中、単回使用内視鏡の需要は増加の一途をたどっています。これらの機器は、安全性と使いやすさという付加的な利点を提供しながら、次世代機能で様々な診断・治療手順をサポートします。これらの使い捨て機器は、医師が病院環境、重症治療室、内視鏡室でより大きな需要に対応することを可能にします。

例えば、Ambuは2024年4月、治療用胃カメラソリューションであるAmbu aScope Gastro LargeとAmbu aBox 2の米国食品医薬品局（FDA）による510（k）規制認可を発表しました。この承認は、上部消化管手術を行う外科医や消化器内科医向けのソリューションの拡充を意味します。aScope GastroとaScope Gastro Largeを含む拡大された内視鏡ポートフォリオにより、医師は手術室、重症治療室、内視鏡室などの病院環境において、より多様な需要に対応できるようになります。

代替診断技術との競合

食道鏡・胃カメラが消化器（GI）疾患の診断と治療に不可欠であることに変わりはあるませんが、代替診断技術との競合が市場の成長にとって課題となってきています。これらの代替技術は、従来の内視鏡検査と競合する非侵襲的で費用対効果が高く、患者への負担が少ない選択肢を提供することが多いです。

CTスキャン（コンピュータ断層撮影法）、MRI（磁気共鳴画像法）、超音波などの非侵襲的画像診断法は、従来の内視鏡検査に代わる選択肢として人気を集めています。これらの画像診断法により、医師は侵襲的な手技を必要とせずに消化管の状態を診断することができ、合併症のリスクを軽減し、患者の快適性を向上させることができます。CTコロノグラフィー（バーチャル大腸内視鏡検査）は、処置時間が短く、患者の不快感が少ないことから、ますます受け入れられつつあります。

カプセル内視鏡検査は、小型カメラを錠剤の形で患者に摂取させるもので、従来の内視鏡検査に代わる非侵襲的な小腸の検査法として人気を集めています。この方法は、特に不明瞭な消化管出血や小腸疾患の場合、食道鏡や胃カメラを必要とせずに、医師が消化管を観察することを可能にします。例えば、Medtronicによると、カプセル内視鏡（PillCamシステムなど）の市場は、特に北米や欧州などの地域で成長しています。これが食道鏡・胃カメラの需要を阻害しています。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • スニペット：製品タイプ別
  • スニペット：ユーザビリティ別
  • スニペット：用途別
  • スニペット：エンドユーザー別
  • スニペット：地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 使い捨て食道鏡・胃カメラの採用増加
    • 抑制要因
      • 代替診断技術との競合
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名なプレーヤー
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 食道鏡・胃カメラ市場、製品タイプ別

  • 食道鏡
    • 硬性食道鏡
    • フレキシブル食道鏡
    • 経鼻食道鏡
    • ファイバーオプティック食道鏡
  • 胃カメラ
    • 硬性胃カメラ
    • フレキシブル胃カメラ
    • 経鼻胃カメラ
    • ビデオ胃カメラ

第6章 食道鏡・胃カメラ市場、ユーザビリティ別

  • 使い捨て
  • 再利用可能

第7章 食道鏡・胃カメラ市場、用途別

  • 食道疾患
  • 胃の病気
  • 食道がん・胃がんの検出
  • 胃組織生検
  • 食道ステント手術
  • その他

第8章 食道鏡・胃カメラ市場、エンドユーザー別

  • 病院
  • 専門クリニック
  • 診断センター
  • 外来手術センター
  • その他

第9章 食道鏡・胃カメラ市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Olympus Corporation
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • FUJIFILM Holdings Corporation
  • Ambu A/S
  • EvoEndo, Inc.
  • EndoMed Systems GmbH
  • Ottomed Endoscopy
  • KARL STORZ
  • Integra LifeSciences Corporation
  • PENTAX Medical
  • Erbe Elektromedizin GmbH

第12章 前提条件と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MI9130

The global esophagoscopes and gastroscopes market reached US$ 1.8 billion in 2024 and is expected to reach US$ 2.9 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

Esophagoscopes are specialized endoscopic instruments used to examine the esophagus, which is the tube that connects the throat to the stomach. These devices are utilized for diagnosing esophageal disorders, such as acid reflux disease (GERD), esophageal cancer, esophageal stricture and foreign body removal. Esophagoscopes can be either rigid or flexible, with flexible esophagoscopes being more commonly used due to their ability to bend and navigate the esophagus comfortably.

Gastroscopes are endoscopic instruments used to examine the stomach and the upper part of the small intestine. These devices are crucial for diagnosing and treating conditions such as gastritis, peptic ulcers, gastric cancers, and H. pylori infection. Similar to esophagoscopes, gastroscopes can be rigid or flexible, with flexible gastroscopes being more widely adopted due to their ability to access various parts of the stomach and the duodenum with ease.

The demand for esophagoscopes and gastroscopes is driven by several key factors, including the increasing prevalence of gastrointestinal (GI) disorders, advancements in endoscopic technology and growing healthcare investments. The increased incidence of gastrointestinal diseases such as gastritis, peptic ulcers, gastroesophageal reflux disease (GERD), esophageal and stomach cancers and other GI disorders significantly fuels the demand for diagnostic and therapeutic endoscopic procedures. For instance, in a recent global study conducted in 33 countries, the authors found that more than 40% of people worldwide have gastrointestinal disorders with higher prevalence in developing countries.

Market Dynamics: Drivers & Restraints

Rising adoption of disposable esophagoscopes and gastroscopes

The rising adoption of disposable esophagoscopes and gastroscopes is significantly driving the growth of the esophagoscopes and gastroscopes market and is expected to drive the market over the forecast period. The COVID-19 pandemic heightened the focus on infection prevention within healthcare settings, especially in endoscopic procedures, where the risk of cross-contamination is high. Reusable esophagoscopes and gastroscopes, if not properly sterilized, can pose serious health risks, including the transmission of hospital-acquired infections (HAIs). The rising preference for disposable esophagoscopes and gastroscopes has led to growing market adoption as hospitals and healthcare providers prioritize patient safety.

For instance, in July 2024, EvoEndo, Inc. released the Model LE 85 Single-Use Gastroscope, providing an additional option for Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract. The Model LE 85 Single-Use Gastroscope is intended to provide optimal patient comfort and physician control when access to the duodenum is not necessary. It has a shorter shaft length and more flexibility for patient safety.

As patients and physicians continue to favor minimally invasive procedures that offer faster recovery times and reduced complication rates, the demand for single-use endoscopes is on the rise. These devices support a variety of diagnostic and therapeutic procedures with next-generation features while offering the added benefit of safety and ease of use. These disposable devices enables doctors to address a larger demands in hospital settings, critical care unit and endoscopic unit.

For instance, in April 2024, Ambu announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its therapeutic gastroscope solution, Ambu aScope Gastro Large and Ambu aBox 2. The approval represents an expanded solution offering for surgeons and gastroenterologists who undertake upper GI operations. The expanded endoscope portfolio, including the aScope Gastro and aScope Gastro Large, enables doctors to address a larger variety of demands in hospital settings such as the operating room, critical care unit and endoscopic unit.

Competition from alternative diagnostic technologies

While esophagoscopes and gastroscopes remain crucial for diagnosing and treating gastrointestinal (GI) disorders, the competition from alternative diagnostic technologies is increasingly presenting challenges to the growth of the market. These alternatives often offer non-invasive, cost-effective, and less patient-invasive options that compete with traditional endoscopy procedures.

Non-invasive imaging techniques, such as CT scans (computed tomography), MRI (magnetic resonance imaging) and ultrasound are gaining traction as alternatives to traditional endoscopic procedures. These imaging methods allow physicians to diagnose gastrointestinal conditions without the need for invasive procedures, reducing the risks of complications and improving patient comfort. CT Colonography (Virtual Colonoscopy) is increasingly gaining acceptance due to its shorter procedure time and less patient discomfort.

Capsule endoscopy, where a small camera is ingested by the patient in the form of a pill, is gaining popularity as a non-invasive alternative to traditional endoscopies for examining the small intestine. This method allows physicians to view the GI tract without the need for esophagoscopes or gastroscopes, particularly in cases of obscure GI bleeding or small bowel conditions. For instance, according to Medtronic, the market for capsule endoscopy (e.g., PillCam systems) is growing, particularly in regions like North America and Europe. Which hampers the demand for esophagoscopes and gastroscopes.

Segment Analysis

The global esophagoscopes and gastroscopes market is segmented based on product type, usability, application, end-user and region.

Product Type:

The gastroscopes segment is expected to dominate the esophagoscopes and gastroscopes market share

Gastrointestinal diseases, such as gastritis, peptic ulcers, esophageal varices, gastric cancer and gastroesophageal reflux disease (GERD), have become increasingly common globally. The demand for gastroscopic procedures to diagnose and treat these conditions is significantly higher compared to esophageal disorders, making gastroscopes a dominant segment.

For instance, gastric cancer is one of the most prevalent cancers globally. According to the World Health Organization (WHO), there are over 1 million new cases of gastric cancer diagnosed annually, leading to an increase in gastroscopy procedures. The prevalence of GERD is growing, particularly in Western countries, where the condition affects approximately 20% of the population, driving the demand for gastroscopes for diagnosis and management.

The market for gastroscopes is also dominated by established companies, which continually improve the technology and increase adoption. Major manufacturers are focusing on innovative features, such as high-definition imaging, advanced gastrointestinal endoscopy and single-use gastroscopes, further enhancing the segment's growth. Companies like Olympus Corporation, Pentax Medical, and Fujifilm lead the market with advanced gastroscopes that include high-definition imaging technology for better diagnosis.

For instance, in May 2023, Olympus Corporation announced the FDA clearance of the new EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within lower digestive tract.

Gastroscopes are commonly used for both diagnostic and therapeutic purposes, which increases their usage frequency. They are not only used to examine the upper GI tract, but also for procedures like biopsy, polyp removal, and stent placement, making them indispensable in modern GI practice. Gastroscopy is a standard procedure for diagnosing gastritis, ulcers, and esophageal cancers. The procedure also plays a critical role in endoscopic ultrasound (EUS) for staging cancers, further solidifying its importance in the medical field.

Geographical Analysis

North America is expected to hold a significant position in the esophagoscopes and gastroscopes market share

North America has one of the highest prevalence rates for esophageal and gastrointestinal diseases, which significantly drives the demand for gastroscopic and esophagoscopic procedures. Conditions like GERD (gastroesophageal reflux disease), gastritis, peptic ulcers, esophageal cancers and irritable bowel syndrome (IBS) are increasingly common, leading to higher utilization of diagnostic procedures involving esophagoscopes and gastroscopes.

For instance, according to the National Institute of Health, GERD affects approximately 20% of the U.S. population. This has led to a growing need for gastroscopies for diagnosis and treatment. Esophageal cancer is also prevalent, with the American Cancer Society estimating that in 2025, about 22,070 new esophageal cancer cases diagnosed (17,430 in men and 4,640 in women) and about 16,250 deaths from esophageal cancer (12,940 in men and 3,310 in women). This further contributes to the high demand for gastroscopic procedures for diagnosis and treatment of associated symptoms.

Leading global players such as Olympus, Medtronic, Pentax Medical and Fujifilm have a strong foothold in the North American market, which supports both the supply and adoption of gastroscopes and esophagoscopes. These companies are focused on innovation and meeting the rising demand for advanced imaging systems, robot-assisted surgeries, and disposable endoscopes.

For instance, Olympus Corporation is one of the largest manufacturers of gastroscopes and esophagoscopes, and the company has a significant market share in North America, driven by the growing demand for high-definition, disposable, and minimally invasive technologies. According to the Olympus Corporation, North American market accounts for about 35% of total sales in the GI endoscopy.

Asia-Pacific is growing at the fastest pace in the esophagoscopes and gastroscopes market

Countries in the Asia Pacific are investing heavily in upgrading their healthcare infrastructure, including the adoption of modern medical technologies such as gastroscopes and esophagoscopes. The development of healthcare facilities and endoscopic centers in both urban and rural areas is improving access to endoscopic diagnostic tools including esophagoscopes and gastroscopes.

For instance, in July 2024, FUJIFILM India launched its second-largest endoscopy equipment service center in Mumbai. The center will handle repairs of gastroscopes and high-end processors. The new facility aims to reduce service turnaround times and improve delivery across India.

With the increasing preference for minimally invasive procedures in Asia Pacific, there is a higher demand for gastroscopic and esophagoscopic procedures, as they offer patients faster recovery times, reduced discomfort and fewer risks compared to traditional surgical methods. For instance, single-use gastroscopes are gaining traction in the region, especially in countries like India and China, where there is a rising demand for affordable, effective diagnostic solutions in hospitals and clinics.

Competitive Landscape

The major global players in the esophagoscopes and gastroscopes market include Olympus Corporation, FUJIFILM Holdings Corporation, Ambu A/S, EvoEndo, Inc., EndoMed Systems GmbH, Ottomed Endoscopy, KARL STORZ, Integra LifeSciences Corporation, PENTAX Medical, Erbe Elektromedizin GmbH and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global esophagoscopes and gastroscopes market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 153 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Usability
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Adoption of Disposable Esophagoscopes and Gastroscopes
    • 3.1.2. Restraints
      • 3.1.2.1. Competition from Alternative Diagnostic Technologies
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Esophagoscopes And Gastroscopes Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Esophagoscopes*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Rigid Esophagoscopes
    • 5.2.4. Flexible Esophagoscopes
    • 5.2.5. Transnasal Esophagoscopes
    • 5.2.6. Fiberoptic Esophagoscopes
  • 5.3. Gastroscopes
    • 5.3.1. Rigid Gastroscopes
    • 5.3.2. Flexible Gastroscopes
    • 5.3.3. Transnasal Gastroscopes
    • 5.3.4. Video Gastroscopes

6. Esophagoscopes And Gastroscopes Market, By Usability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 6.1.2. Market Attractiveness Index, By Usability
  • 6.2. Disposable*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Reusable

7. Esophagoscopes And Gastroscopes Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Esophageal Disorders*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gastric Disorders
  • 7.4. Esophageal and Gastric Cancer Detection
  • 7.5. Gastric Tissue Biopsy
  • 7.6. Esophageal Stent Procedures
  • 7.7. Others

8. Esophagoscopes And Gastroscopes Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Ambulatory Surgical Centers
  • 8.6. Others

9. Esophagoscopes And Gastroscopes Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Olympus Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. FUJIFILM Holdings Corporation
  • 11.3. Ambu A/S
  • 11.4. EvoEndo, Inc.
  • 11.5. EndoMed Systems GmbH
  • 11.6. Ottomed Endoscopy
  • 11.7. KARL STORZ
  • 11.8. Integra LifeSciences Corporation
  • 11.9. PENTAX Medical
  • 11.10. Erbe Elektromedizin GmbH

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us